Stephen M. Novak
Tracked across 1 events · 6 articles · First seen Apr 17, 2026 · Last active Apr 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Stephen M. Novak was appointed Chief of Research and Development at Onco-Innovations, responsible for leading end-to-end development operations and aligning key development partners.
Apr 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Stephen M. Novak live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard